Cargando…
MS Care in Novel Coronavirus 19 Pandemic
Autores principales: | Ramezani, Neda, Adibi, Iman, Mirmosayyeb, Omid, Shaygannejad, Vahid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7518361/ https://www.ncbi.nlm.nih.gov/pubmed/33042495 http://dx.doi.org/10.4103/ijpvm.IJPVM_242_20 |
Ejemplares similares
-
Managing anxiety among multiple sclerosis patients during COVID-19 pandemic
por: Adibi, Iman, et al.
Publicado: (2021) -
Paraparesis due to aortic thromboembolism as a rare complication of COVID-19 infection
por: Motahharynia, Ali, et al.
Publicado: (2021) -
Presentation of Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL) in the Acute Phase of COVID-19 Infection
por: Jalilian, Zeynab, et al.
Publicado: (2023) -
Fear of relapse, social support, and psychological well-being (depression, anxiety, and stress level) of patients with multiple sclerosis (MS) during the COVID-19 pandemic stage
por: Shaygannejad, Vahid, et al.
Publicado: (2021) -
Predictors of Catching COVID-19 Infection during Pandemic Stage in Patients with Multiple Sclerosis (MS)
por: Ghajarzadeh, Mahsa, et al.
Publicado: (2022)